NovaBay Pharmaceuticals SG&A Expense (Quarterly) Analysis

NovaBay Pharmaceuticals Inc (NBY)

0.0788 0.00 (0.00%) USD | NYAM | Apr 26, 16:00

0.0781 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2023	2.609M
September 30, 2023	2.943M
June 30, 2023	3.634M
March 31, 2023	3.644M
December 31, 2022	4.378M
September 30, 2022	2.791M
June 30, 2022	3.95M
March 31, 2022	4.168M
December 31, 2021	4.864M
September 30, 2021	3.832M
June 30, 2021	3.357M
March 31, 2021	2.867M
December 31, 2020	2.797M
September 30, 2020	3.571M
June 30, 2020	2.90M
March 31, 2020	2.837M
December 31, 2019	3.331M
September 30, 2019	2.877M
June 30, 2019	2.733M
March 31, 2019	5.136M
December 31, 2018	4.688M
September 30, 2018	4.574M
June 30, 2018	4.337M
March 31, 2018	5.018M
December 31, 2017	4.801M

Date	Value
September 30, 2017	5.607M
June 30, 2017	5.111M
March 31, 2017	6.828M
December 31, 2016	5.143M
September 30, 2016	4.929M
June 30, 2016	4.146M
March 31, 2016	4.826M
December 31, 2015	6.088M
September 30, 2015	4.716M
June 30, 2015	4.257M
March 31, 2015	3.468M
December 31, 2014	2.716M
September 30, 2014	1.911M
June 30, 2014	1.653M
March 31, 2014	1.708M
December 31, 2013	1.259M
September 30, 2013	1.525M
June 30, 2013	2.045M
March 31, 2013	1.56M
December 31, 2012	1.828M
September 30, 2012	1.234M
June 30, 2012	1.368M
March 31, 2012	1.541M
December 31, 2011	1.499M
September 30, 2011	1.097M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.609M

Minimum

Dec 2023

4.864M

Maximum

Dec 2021

3.373M

Average

3.331M

Median

Dec 2019

SG&A Expense (Quarterly) Benchmarks